The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Barriers to BRCA, HRD, and HRRm testing despite increased utilization: U.S. physician survey results.
 
Elizabeth A. Szamreta
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ning Ning
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Bristol Myers Squibb (Inst); Daiichi Sankyo (Inst); Merck (Inst); Otsuka (Inst); Takeda (Inst)
 
Bianca Jackson
No Relationships to Disclose
 
Ruchit Shah
Employment - Daiichi Sankyo
Consulting or Advisory Role - Merck (Inst)
 
Jyoti Aggarwal
Employment - Otsuka
Consulting or Advisory Role - Merck (Inst)
 
Gboyega Adeboyeje
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Merck
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); FORMA Therapeutics (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Nektar (Inst); Orion (Inst); Pfizer (Inst); POINT Biopharma (Inst); Progenics (Inst); Roche/Genentech (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst)